Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors

Clinical trial NCT04234568 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT04234568

Sponsor

National Cancer Institute (NCI)

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2020-07-20

Primary completion

2024-09-17

Enrollment

31

View on ClinicalTrials.gov